NK/T-CELL LYMPHOMA

Clinical trials for NK/T-CELL LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new NK/T-CELL LYMPHOMA trials appear

Sign up with your email to follow new studies for NK/T-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 5 Not yet finished but already full! 3 Completed 1 Terminated 1

Experimental drug shows promise for Hard-to-Treat lymphoma

Disease control Completed

This study tested a drug called brentuximab vedotin in 23 people with a type of T-cell lymphoma that had stopped responding to or returned after prior chemotherapy. The drug is designed to seek out and kill cancer cells that have a specific marker called CD30, even when levels of…

Matched conditions: NK/T-CELL LYMPHOMA

Phase: PHASE2 • Sponsor: Deepa Jagadeesh • Aim: Disease control

Last updated Jun 27, 2026 07:58 UTC

NK/T-CELL LYMPHOMA

Get alerted when new NK/T-CELL LYMPHOMA trials appear

Experimental drug shows promise for Hard-to-Treat lymphoma